JP2021519315A5 - - Google Patents
Info
- Publication number
- JP2021519315A5 JP2021519315A5 JP2020551992A JP2020551992A JP2021519315A5 JP 2021519315 A5 JP2021519315 A5 JP 2021519315A5 JP 2020551992 A JP2020551992 A JP 2020551992A JP 2020551992 A JP2020551992 A JP 2020551992A JP 2021519315 A5 JP2021519315 A5 JP 2021519315A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- rna virus
- condition
- keratitis
- Prior art date
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023035224A JP7745584B2 (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| JP2025076718A JP2025118771A (ja) | 2018-03-27 | 2025-05-02 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862648585P | 2018-03-27 | 2018-03-27 | |
| US62/648,585 | 2018-03-27 | ||
| US201862693021P | 2018-07-02 | 2018-07-02 | |
| US62/693,021 | 2018-07-02 | ||
| PCT/US2019/023977 WO2019191026A2 (en) | 2018-03-27 | 2019-03-26 | Methods for the use of 5'-adenosine diphosphate ribose (adpr) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023035224A Division JP7745584B2 (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021519315A JP2021519315A (ja) | 2021-08-10 |
| JPWO2019191026A5 JPWO2019191026A5 (https=) | 2022-04-01 |
| JP2021519315A5 true JP2021519315A5 (https=) | 2022-04-01 |
| JP7242696B2 JP7242696B2 (ja) | 2023-03-20 |
Family
ID=66647439
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551992A Active JP7242696B2 (ja) | 2018-03-27 | 2019-03-26 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| JP2023035224A Active JP7745584B2 (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| JP2025076718A Pending JP2025118771A (ja) | 2018-03-27 | 2025-05-02 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023035224A Active JP7745584B2 (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| JP2025076718A Pending JP2025118771A (ja) | 2018-03-27 | 2025-05-02 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10946034B2 (https=) |
| EP (2) | EP4226971A1 (https=) |
| JP (3) | JP7242696B2 (https=) |
| ES (1) | ES2949441T3 (https=) |
| WO (1) | WO2019191026A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102622656B1 (ko) | 2016-02-18 | 2024-01-10 | 인버사, 인크. | 5'-아데노신 디포스페이트 리보오스 (adpr)의 사용 방법 |
| WO2019191026A2 (en) | 2018-03-27 | 2019-10-03 | Invirsa, Inc. | Methods for the use of 5'-adenosine diphosphate ribose (adpr) |
| CN111714619B (zh) * | 2020-07-15 | 2023-03-14 | 上海市浦东新区人民医院 | 成纤维生长因子6在制备缓解非酒精性脂肪性肝炎肝损伤的药物中的应用 |
| CN112972453B (zh) * | 2021-03-05 | 2022-04-15 | 中国人民解放军军事科学院军事医学研究院 | MDL-800在制备抑制SARS-CoV-2病毒易感性药物中的应用 |
| KR102789553B1 (ko) * | 2021-09-07 | 2025-04-03 | 주식회사 펄스인마이어스 | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 |
| WO2025122455A1 (en) * | 2023-12-04 | 2025-06-12 | Invirsa, Inc. | Methods for the use of 5'-adenosine diphosphate ribose (adpr) for vegf modulation |
| WO2025259632A1 (en) * | 2024-06-12 | 2025-12-18 | Sirtsei Pharmaceuticals, Inc. | Compositions and methods for treating retinal diseases or conditions |
| WO2026073064A1 (en) * | 2024-09-30 | 2026-04-02 | Invirsa, Inc. | 5'-adenosine diphosphate ribose (adpr) for use in improving visual acuity |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04273826A (ja) * | 1991-02-27 | 1992-09-30 | Dainippon Ink & Chem Inc | 抗ｒｓウイルス剤 |
| EP0618214A1 (en) | 1993-04-01 | 1994-10-05 | Merrell Dow Pharmaceuticals Inc. | Unsaturated phosphonate derivatives of purines and pyrimidines |
| JPH07247210A (ja) | 1994-03-09 | 1995-09-26 | Sunstar Inc | 口腔用組成物 |
| JP2001515916A (ja) | 1997-09-11 | 2001-09-25 | オクシジェン，インコーポレイテッド | 悪性および伝染性疾患の治療用にニコチンアミド・アデニン・ジヌクレオチドならびにその類似物を用いる治療法 |
| WO2000050024A2 (en) | 1999-02-26 | 2000-08-31 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| EP1192258A2 (en) | 1999-06-16 | 2002-04-03 | Icos Corporation | Human poly(adp-ribose) polymerase 2 materials and methods |
| US6528042B1 (en) | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
| US7115585B2 (en) | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| EP1409503A1 (en) | 2001-07-25 | 2004-04-21 | Celltech R & D Limited | Non-natural carbon-linked nucleotides and dinucleotides |
| AU2003230952A1 (en) | 2002-05-21 | 2003-12-12 | Abbott Laboratories | Treatment of mucositis |
| JP2005089450A (ja) | 2003-08-11 | 2005-04-07 | Fujisawa Pharmaceut Co Ltd | Ｒｓウィルスによる感染症の予防または治療剤 |
| US20070212395A1 (en) | 2006-03-08 | 2007-09-13 | Allergan, Inc. | Ocular therapy using sirtuin-activating agents |
| US20050276762A1 (en) | 2004-06-15 | 2005-12-15 | Tapas Das | Topical compositions containing 5'-adenosine-diphosphate ribose |
| WO2006127987A2 (en) | 2005-05-25 | 2006-11-30 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
| EP1948215B1 (en) | 2005-11-14 | 2012-01-11 | Centre National De La Recherche Scientifique (Cnrs) | MacroH2A non-histone domain as inhibitor of PARP-1 activity and uses thereof |
| WO2008154129A1 (en) | 2007-06-08 | 2008-12-18 | Bausch & Lomb Incorporated | Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| US20110217262A1 (en) | 2010-03-05 | 2011-09-08 | Kornfield Julia A | Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability |
| JP2013526514A (ja) | 2010-05-10 | 2013-06-24 | ラディカル・セラピューティックス・インコーポレイテッド | リポ酸およびニトロキシド誘導体およびその使用 |
| KR101967938B1 (ko) | 2011-05-12 | 2019-04-10 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 스테로이드 또는 비-스테로이드성 소염제를 갖는 안정한 포비돈-요오드 조성물 |
| US20160287622A1 (en) | 2013-11-18 | 2016-10-06 | Massachusetts Institute Of Technology | Compositions and methods for treating immune and viral disorders and modulating protein-rna interaction |
| KR102622656B1 (ko) * | 2016-02-18 | 2024-01-10 | 인버사, 인크. | 5'-아데노신 디포스페이트 리보오스 (adpr)의 사용 방법 |
| WO2019191026A2 (en) | 2018-03-27 | 2019-10-03 | Invirsa, Inc. | Methods for the use of 5'-adenosine diphosphate ribose (adpr) |
-
2019
- 2019-03-26 WO PCT/US2019/023977 patent/WO2019191026A2/en not_active Ceased
- 2019-03-26 EP EP23168073.7A patent/EP4226971A1/en active Pending
- 2019-03-26 JP JP2020551992A patent/JP7242696B2/ja active Active
- 2019-03-26 US US16/364,760 patent/US10946034B2/en active Active
- 2019-03-26 EP EP19726521.8A patent/EP3773604B1/en active Active
- 2019-03-26 ES ES19726521T patent/ES2949441T3/es active Active
-
2021
- 2021-02-09 US US17/171,548 patent/US11793826B2/en active Active
-
2023
- 2023-03-08 JP JP2023035224A patent/JP7745584B2/ja active Active
- 2023-09-11 US US18/244,693 patent/US12233083B2/en active Active
-
2025
- 2025-01-17 US US19/029,481 patent/US20250161343A1/en not_active Abandoned
- 2025-05-02 JP JP2025076718A patent/JP2025118771A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519315A5 (https=) | ||
| ES2553788T3 (es) | 3,5-diamino-6-cloro-N-(N-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazino-2-carboxamida | |
| JP2023071933A5 (https=) | ||
| US5789391A (en) | Method of treating sinusitis with uridine triphosphates and related compounds | |
| JP6392241B2 (ja) | ３，５−ジアミノ−６−クロロ−ｎ−（ｎ−（４−フェニルブチル）カルバムイミドイル）ピラジン−２−カルボキサミド化合物 | |
| EP0889728B1 (en) | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds | |
| JP6021117B2 (ja) | エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用 | |
| CN105073717B (zh) | 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物 | |
| JP2014518268A5 (https=) | ||
| ES2949441T3 (es) | Métodos para el uso de 5'-adenosina difosfato ribosa (ADPR) | |
| BR112017005104B1 (pt) | Derivados de 5,6-di-hidro-4h-benzotieno-[2,3-d]azepina, seus usos, composição farmacêutica e processo para a preparação dos mesmos | |
| JP2010502738A (ja) | ナトリウムチャネル遮断剤および浸透圧調節物質での処置により粘膜水和および粘膜クリアランスを増強する方法 | |
| JP2019505596A5 (https=) | ||
| HRP20211942T1 (hr) | Medicinska uporaba 5'-adenozin difosfat riboze (adpr) | |
| JP2016503031A (ja) | アリールアルキル及びアリールオキシアルキル置換の上皮ナトリウムチャネル遮断化合物 | |
| JPWO2019191026A5 (https=) | ||
| BR112018074532B1 (pt) | Composição farmacêutica, aerossol, e, kit. | |
| US20110166149A1 (en) | Pteridine derivatives for treating respiratory disease | |
| CN104507918A (zh) | 用于治疗或预防肺炎病毒感染和相关疾病的组合物和方法 | |
| AU2006263447B2 (en) | P2Y6 receptor agonists for treating lung diseases | |
| US20030036527A1 (en) | Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds | |
| ES2239728T3 (es) | Combinaciones farmaceuticas de agonistas del receptor de adenosina a-2a y del receptor adrenergico beta-2. | |
| WO2021253647A1 (zh) | 小分子抑制剂在治疗呼吸道病毒性肺炎上的应用 | |
| EP1941883A1 (en) | Use of sodium blockers for an early therapy of obstructive lung diseases | |
| CN101237772A (zh) | 用于治疗肺病的p2y6受体激动剂 |